MHP
PACB icon

Manatuck Hill Partners’s Pacific Biosciences PACB Stock Holding History

Manatuck Hill Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-200,000
Closed -$506K – 108
2013
Q2 		$506K Buy
+200,000
New +$498K 0.06% 81

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Manatuck Hill Partners's PACB Position: Q3 2013 in Review

Manatuck Hill Partners sold out of Pacific Biosciences (PACB) in Q3 2013, closing a stake of 200,000 shares — an estimated $506K sold.

Manatuck Hill Partners first reported a position in PACB in Q2 2013 and held it in 1 quarter. The position peaked at $506K in Q2 2013. 81 funds tracked by Wall St. Rank hold PACB as of Q3 2013.

  • Manatuck Hill Partners reported no remaining Pacific Biosciences position as of Q3 2013 after selling out during the quarter.
  • Manatuck Hill Partners sold 200,000 Pacific Biosciences shares in Q3 2013, an estimated $506K.
  • Manatuck Hill Partners first reported a position in Pacific Biosciences in Q2 2013 and held it in 1 quarter.
  • Manatuck Hill Partners's Pacific Biosciences position peaked at $506K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2013.

Based on Manatuck Hill Partners's 13F filing for Q3 2013, filed 14 Nov 2013.